|
|
|
|
| LEADER |
01888nam a22003015i 4500 |
| 001 |
000293330 |
| 005 |
20210609114113.0 |
| 007 |
cr nn 008mamaa |
| 008 |
110322s2011 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9789400704404
|
| 024 |
7 |
|
|a 10.1007/978-94-007-0440-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
4 |
|a The Myelodysplastic Syndromes /
|c edited by Judit Várkonyi.
|
| 250 |
|
|
|a 1st ed. 2011.
|
| 260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2011.
|
| 300 |
|
|
|a XIII, 286 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a 1. PREFACE -- 2. The history of the Myelodysplastic Syndromes -- 3. Susceptibility to MDS: DNA repair and detoxification genes -- 4. Myelodysplastic syndromes/neoplasms: Morphological and Immunohistochemical features and standard evaluation -- 5. Diagnostic Criteria and Classification of Myelodysplastic Syndromes -- 6. Cytogenetics of MDS -- 7. Molecular changes in myelodysplastic syndrome -- 8. Prognostic Scoring in MDS -- 9. Flow Cytometry in Myelodysplastic Syndromes -- 10. MDS as an Autoimmune Process -- 11. The Myelodysplastic Overlap Syndromes -- 12. Iron and copper Metabolismin the Myelodysplastic Syndromes -- 13. Pathogenesis and Management of Iron Overload in MDS -- 14. Cytokines in MDS. Abnormalities and treatment -- 15. Therapeutic Modalities and new molecular targets in MDS -- 16. Haematopoietic Stem Cell Transplantation in MDS for Adults -- 17. JMML and Myelodysplastic Syndrome in children.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Hematology.
|
| 650 |
1 |
4 |
|a Biomedicine, general.
|
| 650 |
2 |
4 |
|a Hematology.
|
| 650 |
2 |
4 |
|a Medicine/Public Health, general.
|
| 700 |
1 |
|
|a Várkonyi, Judit.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|